BEAM vs FRT
Beam Therapeutics Inc (BEAM) versus FRT (FRT) — a side-by-side from cached financials, not a winner call.
Beam Therapeutics Inc (BEAM) is a biotechnology company listed on US.
FRT (FRT) common stock.
Latest reported BEAM revenue for 2024-12-31 was $63.5M. Net income was -$376.7M. Revenue was down 83.2% from 2023-12-31 to 2024-12-31. BEAM currently screens at market cap $2.01B.
FRT does not have a complete income-statement cache yet.
BEAM currently screens at market cap $2.01B. FRT currently screens at market cap $0.
Not investment advice. Open the BEAM and FRT stock pages for the full models.
Not investment advice.